Cecropin (1-12) [I8A, E9A, V11K]

General Information


DRACP ID  DRACP02643

Peptide Name   Cecropin (1-12) [I8A, E9A, V11K]

Sequence  RWKIFKKAAKKG

Sequence Length  12

UniProt ID  P14666 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
RAW 264.7 Mouse leukemia Leukemia Not active up to 50 µM MTT assay Not available 1

Hemolytic Activity  Human erythrocytes: HC10=200 µM

Normal (non-cancerous) Cytotoxicity  HaCat: Not active up to 50 µM; HEK293: Not active up to 50 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02643

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C70H117N21O13

Absent amino acids  CDEHLMNPQSTVY

Common amino acids  K

Mass  165722

Pl  12.05

Basic residues  6

Acidic residues  0

Hydrophobic residues  5

Net charge  6

Boman Index  -2788

Hydrophobicity  -120

Aliphatic Index  49.17

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  500

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30846839

Title  Development of a novel short 12-meric papiliocin-derived peptide that is effective against Gram-negative sepsis

Doi 10.1038/s41598-019-40577-8

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.